Diagnostic value of MPO plasma levels in patients admitted for suspected myocardial infarction.

  • Volker Rudolph
  • Britta Goldmann
  • Constantin Boes
  • Tanja Katharina Rudolph
  • Anna Klinke
  • Kai Friedrichs
  • Denise Lau
  • Karl Wegscheider
  • Munif Haddad
  • Thomas Meinertz
  • Stephan Baldus

Abstract

Besides its well-established role in atherosclerosis, myeloperoxidase (MPO) has gained attention as a prognostic indicator in cardiovascular disease. Previous studies assessed MPO retrospectively and at a single time point. The current study aimed to evaluate the prognostic information of MPO prospectively and in consecutive measurements in patients presenting with chest pain.

Bibliographical data

Original languageEnglish
Article number3
ISSN0167-5273
Publication statusPublished - 2011
pubmed 20846733